Literature DB >> 2471129

Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins.

M Lipp1, R Schilling, G Bernhardt.   

Abstract

The detailed mechanisms leading to transcriptional activation of the human MYC oncogene in general as well as in certain tumor cells are poorly understood. In view of the ability of a number of viral oncogenes to stimulate transcription in trans, the identification of cellular target genes could contribute to the understanding of components of the transformation process. It is demonstrated that the human MYC promoter is such an efficient target for the trans-acting activity mediated by E1a proteins of adenoviruses (Ad). Using the chloramphenicol acetyltransferase (CAT) gene as a marker for promoter activity, co-transfection of constructs containing both MYC promoters and most of the untranslated first exon with plasmids expressing the E1a gene of different adenoviruses stimulates CAT activity up to 24-fold. Trans-activation depends upon the presence of the second promoter (P2), and transcription is initiated at the authentic cap site of P2. This observation is confirmed by the behaviour of stably transformed cell lines carrying single or multiple copies of MYC-cat constructs, which were transfected either with E1a-expressing plasmids, infected with Ad5, or fused with 293 cells constitutively expressing E1a protein. These results suggest that E1a proteins can lead to an imbalance of the regulation of the human MYC gene, which might be a sufficient prerequisite for initiation and progression of transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471129

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Role of E2F transcription factor in E1A-mediated trans activation of cellular genes.

Authors:  S W Hiebert; M Blake; J Azizkhan; J R Nevins
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

Authors:  D Melamed; N Tiefenbrun; A Yarden; A Kimchi
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

3.  E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection.

Authors:  M Wade; T F Kowalik; M Mudryj; E S Huang; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.

Authors:  D Eick
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

5.  Mutual interference of adenovirus infection and myc expression.

Authors:  Kristina Löhr; Oliver Hartmann; Helmut Schäfer; Matthias Dobbelstein
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

6.  Yin-yang 1 activates the c-myc promoter.

Authors:  K J Riggs; S Saleque; K K Wong; K T Merrell; J S Lee; Y Shi; K Calame
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 7.  Myc oncogenes: the enigmatic family.

Authors:  K M Ryan; G D Birnie
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

8.  The adenoviral E1A N-terminal domain represses MYC transcription in human cancer cells by targeting both p300 and TRRAP and inhibiting MYC promoter acetylation of H3K18 and H4K16.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Genes Cancer       Date:  2016-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.